Oxygen Therapy for the Treatment of Undifferentiated Headache in the Emergency Department

NCT ID: NCT00856232

Last Updated: 2016-04-21

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

91 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2011-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will randomly assign emergency department patients seeking treatment for a headache to one of three groups. The first group will receive standard emergency care as determined by the treating physician, the second group will breathe high flow air by facemask for 15 minutes, and the third group will breathe high flow oxygen by face mask for 15 minutes. The patients will be questioned in the beginning of their treatment and at 2, 5, 10, 15 and 30 minutes after it's begun about the intensity of their headache and how much relief they are experiencing from their treatment. Concentration of carbon dioxide exhaled by patients will also be recorded at 0, 2, 5, 10, 15 and 30 minutes. After fifteen minutes, the patients in groups 2 and 3 will continue with standard emergency care, which can include any treatment their physician sees fit. Patients in all three groups will receive a stopwatch in the beginning of their emergency department visit and record the total extent of time their headache will take to resolve.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Thorough description provided in brief summary.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Headache

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard therapy

Standard emergency department evaluation and treatment for headache

Group Type NO_INTERVENTION

No interventions assigned to this group

Medical Air

Air inhalation at 15L / min x 15 minutes followed by standard emergency department evaluation and treatment for headache

Group Type PLACEBO_COMPARATOR

Medical Air

Intervention Type BIOLOGICAL

Compressed medical air

Oxygen

Oxygen inhalation at 15 L/min for 15 minutes followed by standard emergency department evaluation and treatment for headache

Group Type EXPERIMENTAL

Oxygen

Intervention Type BIOLOGICAL

Medical Oxygen

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Medical Air

Compressed medical air

Intervention Type BIOLOGICAL

Oxygen

Medical Oxygen

Intervention Type BIOLOGICAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients who describe a painful sensation in the head as one of the primary reasons for their visit to the ED.

Exclusion Criteria

* patients who need immediate oxygen after triage: Recent fire or carbon monoxide exposure\_\_\_\_\_\_\_ O2 saturation 94% or less on room air on triage vitals \_\_\_\_\_\_ patient arrives on supplemental oxygen\_\_\_\_\_\_\_ patient reports shortness of breath\_\_\_\_\_\_\_
* patients in whom 100% oxygen is contraindicated, potentially undesirable, or controversial: history of COPD\_\_\_\_\_\_\_ possible cardiac ischemia (mouth / jaw / neck / shoulder / chest / abdomen pain or pressure)\_\_\_\_\_\_\_ possible stroke (new focal weakness or numbness, speech, hearing or vision deficit, bowel or bladder incontinence or retention)\_\_\_\_\_
* patients unable to tolerate the gas treatment: patient not able to tolerate a face mask\_\_\_\_\_\_\_ patient requests immediate treatment with another preferred therapeutic agent\_\_\_\_\_\_\_
* treating physician or nurse request to discontinue the study at any point\_\_\_\_\_\_\_
* patients who have diminished decision-making capacity history of mental retardation or pervasive developmental disorder\_\_\_\_\_\_\_ patient not awake and alert\_\_\_\_\_\_\_ patient not oriented to self, month and year, and current location\_\_\_\_\_\_\_ patient unwilling or unable to fully participate in the research associate interview and consent process\_\_\_\_\_\_\_
* patients who are at risk for intracranial hemorrhage history of intracranial aneurythm, hemorrhage, surgery, or tumor\_\_\_\_\_\_\_ current headache began after trauma\_\_\_\_\_\_\_ current headache began after using elicit drugs\_\_\_\_\_\_\_
* patients who are at high risk for intracranial infection fever \> 100.4 F on triage vitals\_\_\_\_\_\_\_ complaining of recent onset neck stiffness\_\_\_\_\_\_\_
* patients who are at high risk for extracranial head pathology ear pain or drainage\_\_\_\_\_\_\_ tooth or gum pain\_\_\_\_\_\_\_ headache localized to a skin lesion on the head\_\_\_\_\_\_
* patient is potentially critically ill active bleeding from any source\_\_\_\_\_\_\_ heart rate \<60 or \>130 on triage vitals\_\_\_\_\_\_\_ systolic blood pressure \<90 or \>180 on triage vitals\_\_\_\_\_\_\_ respiratory rate \< 10 or \>30 on triage vitals\_\_\_\_\_\_\_
* patient is younger than 21\_\_\_\_\_\_\_
* patients who know or suspect they are pregnant \_\_\_\_\_
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Medicine and Dentistry of New Jersey

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

rwjms-ed

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boris D Veysman, M.D.

Role: PRINCIPAL_INVESTIGATOR

Department of Emergency Medicine, UMDNJ - Robert Wood Johnson Medical School

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Robert Wood Johnson University Hospital Emergency Department

New Brunswick, New Jersey, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0220080056

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Inhaled Nitric Oxide in Brain Injury
NCT03260569 COMPLETED PHASE3
Female Concussion Head Cooling
NCT07303933 NOT_YET_RECRUITING NA